Comparison of intravenous anesthetic agents for the treatment of refractory status epilepticus

Research output: Contribution to journalReview articlepeer-review

Abstract

Status epilepticus that cannot be controlled with first- and second-line agents is called refractory status epilepticus (RSE), a condition that is associated with significant morbidity and mortality. Most experts agree that treatment of RSE necessitates the use of continuous infusion intravenous anesthetic drugs such as midazolam, propofol, pentobarbital, thiopental, and ketamine, each of which has its own unique characteristics. This review compares the various anesthetic agents while providing an approach to their use in adult patients, along with possible associated complications.
Original languageEnglish
Article number54
JournalJournal of Clinical Medicine
Volume5
Issue number5
DOIs
StatePublished - May 1 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2016 by the authors; licensee MDPI, Basel, Switzerland.

ASJC Scopus Subject Areas

  • General Medicine

Keywords

  • IV anesthetics
  • Refractory status epilepticus
  • Status epilepticus

Fingerprint

Dive into the research topics of 'Comparison of intravenous anesthetic agents for the treatment of refractory status epilepticus'. Together they form a unique fingerprint.

Cite this